Department of Clinical Sciences, Neurology, Lund University, Lund, Sweden.
Eur J Hum Genet. 2012 Jul;20(7):783-9. doi: 10.1038/ejhg.2012.4. Epub 2012 Jan 25.
Previous reports have shown ambiguous findings regarding the possible associations between ischaemic stroke (IS) and single nucleotide polymorphisms (SNPs) in the phosphodiesterase 4D (PDE4D) gene region. The SNP rs12188950 (or SNP45) has often been studied in this context. We performed a multi-centre study involving a large sample of 2599 IS patients and 2093 control subjects from the south and west regions of Sweden to replicate previous studies regarding IS risk and rs12188950. Subjects from Lund Stroke Register (LSR), Malmö Diet and Cancer Study (MDC) and Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS) were enroled. Subgroups of participants with hypertension and participants <55 years of age, as well as the TOAST subgroups large vessel disease, small vessel disease and cardioembolism, were also assessed. Univariate odds ratios (ORs) and ORs controlling for hypertension, diabetes and current smoking were calculated. We additionally performed a meta-analysis including 10,500 patients and 10,102 control subjects from 17 publications (including the present study). When assessing pooled data from LSR, MDC and SAHLSIS we obtained no association between IS and rs12188950 for all participants (OR=0.93; 95% confidence interval (CI): 0.83-1.05). Significant associations were not found for hypertensive participants or participants with age <55, or when separately evaluating patients from the three different TOAST subgroups. The meta-analysis showed no significant overall estimate (OR=0.96; 95% CI: 0.89-1.04) with significant heterogeneity for random effect (P=0.042). No effect from rs12188950 on IS was found from either our pooled multi-centre data or the performed meta-analysis. We did not find any association between the examined subgroups and rs12188950 either.
先前的报告表明,缺血性中风(IS)与磷酸二酯酶 4D(PDE4D)基因区域中单核苷酸多态性(SNP)之间可能存在关联,这一结果并不明确。在这种情况下,SNP rs12188950(或 SNP45)经常被研究。我们进行了一项多中心研究,该研究涉及来自瑞典南部和西部的 2599 名 IS 患者和 2093 名对照受试者的大样本,旨在复制先前关于 IS 风险和 rs12188950 的研究。该研究纳入了隆德中风登记处(LSR)、马尔默饮食与癌症研究(MDC)和萨赫勒格兰斯卡缺血性中风研究(SAHLSIS)的受试者。还评估了高血压亚组和年龄<55 岁的参与者亚组,以及 TOAST 亚组中的大血管疾病、小血管疾病和心源性栓塞。计算了单变量比值比(OR)和控制高血压、糖尿病和当前吸烟的 OR。我们还进行了一项荟萃分析,纳入了来自 17 篇出版物(包括本研究)的 10500 名患者和 10102 名对照受试者。当评估 LSR、MDC 和 SAHLSIS 的汇总数据时,我们发现所有参与者的 IS 与 rs12188950 之间没有关联(OR=0.93;95%置信区间(CI):0.83-1.05)。在高血压参与者或年龄<55 岁的参与者中,或在分别评估来自三个不同 TOAST 亚组的患者时,未发现显著关联。荟萃分析显示,总体估计值没有显著意义(OR=0.96;95%CI:0.89-1.04),随机效应存在显著异质性(P=0.042)。无论是从我们的多中心汇总数据还是从进行的荟萃分析来看,都没有发现 rs12188950 对 IS 有任何影响。我们也没有发现所检查的亚组与 rs12188950 之间存在任何关联。